Abstract P5-20-07: Phase II Trial of Dasatinib in Combination With Weekly Paclitaxel for Patients with Metastatic Breast Carcinoma

2012 ◽  
Author(s):  
PG Morris ◽  
D Lake ◽  
HL McArthur ◽  
T Gilewski ◽  
C Dang ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Weekly Paclitaxel ◽  
Metastatic Breast Carcinoma

A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma

Cancer ◽  
2003 ◽  
Vol 97 (3) ◽  
pp. 537-544 ◽  
Author(s):  
Amy D. Tiersten ◽  
Caron Nelsen ◽  
Susan Talbot ◽  
Linda Vahdat ◽  
Robert Fine ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma

Phase II trial of bruceantin in metastatic breast carcinoma

1982 ◽  
Vol 5 (4) ◽  
pp. 389-392 ◽  
Author(s):  
Charles L. Wiseman ◽  
Hwee-Yong Yap ◽  
Agop Y. Bedikian ◽  
Gerald P. Bodey ◽  
George R. Blumenschein
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma

Phase II Trial of Navelbine and Fluorouracil as Second-Line Chemotherapy in Metastatic Breast Carcinoma

Oncology ◽  
1997 ◽  
Vol 55 (1) ◽  
pp. 87-88 ◽  
Author(s):  
Marios E. Froudarakis ◽  
Gilles Catimel ◽  
Jean-Paul Guastalla ◽  
Paul Rebattu ◽  
Michel Clavel
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Second Line ◽  
Metastatic Breast Carcinoma ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma

Cancer ◽  
1996 ◽  
Vol 78 (9) ◽  
pp. 1906-1911 ◽  
Author(s):  
Suzanne D. Conzen ◽  
Peter A. Kaufman ◽  
Christine Arvizu ◽  
Paul LeMarbre ◽  
L. Herbert Maurer ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma

Phase II Trial of Cisplatin and Etoposide as First-Line Therapy in Metastatic Breast Carcinoma

Oncology ◽  
1994 ◽  
Vol 51 (4) ◽  
pp. 352-355 ◽  
Author(s):  
A. Lluch ◽  
P. Azagra ◽  
A. Cervantes ◽  
M. Muñoz ◽  
V. Alberola ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
Metastatic Breast Carcinoma ◽  
First Line Therapy ◽  
Line Therapy

A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma

Cancer ◽  
1997 ◽  
Vol 80 (2) ◽  
pp. 218-224 ◽  
Author(s):  
James N. Ingle ◽  
Patricia A. Johnson ◽  
Vera J. Suman ◽  
James B. Gerstner ◽  
James A. Mailliard ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Hormonal Therapy ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma ◽  
Randomized Phase Ii ◽  
Third Line

scholarly journals A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma

Cancer ◽  
2001 ◽  
Vol 92 (10) ◽  
pp. 2517-2522 ◽  
Author(s):  
William J. Gradishar ◽  
Patricia Stephenson ◽  
Donna J. Glover ◽  
Donna S. Neuberg ◽  
Melvin R. Moore ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma

scholarly journals Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma

Cancer ◽  
2002 ◽  
Vol 95 (10) ◽  
pp. 2044-2050 ◽  
Author(s):  
Chiun Hsu ◽  
Chiun-Sheng Huang ◽  
Tsu-Yi Chao ◽  
Yen-Shen Lu ◽  
Ching-Fang Bu ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma
Sign in / Sign up

Export Citation Format

Share Document